Newcomers will not only be plugging into UPS while its forward-looking yield stands at 7.4%, but while the stock's priced ...

Pfizer should have different top-selling drugs in 2030 with a heavier focus on oncology. The drugmaker should be more ...

Pfizer(NYSE: PFE) is in that group, in my opinion. The big drugmaker's forward dividend yield currently stands at just under 6%, and I think there are three factors that make its ultra-high-yield ...

We recently published a list of Was Jim Cramer Right About These 9 Stocks? In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks that Jim Cramer ...

Keith Speights (Pfizer): I'll readily admit that, at first glance, Pfizer doesn't look like a no-brainer stock to buy. The big drugmaker's share price has plunged roughly 60% from its COVID-19 ...

We recently published a list of Was Jim Cramer Right About These 12 Stocks? In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks that Jim Cramer ...